Concepedia
Statistics
Publications
8
Citations
506
H-Index
Active since
1992
Affiliations
National Cancer Institute(Current)
Frederick National Laboratory for Cancer Research
Genesis Laboratories
Science Applications International Corporation (United States)
LabCorp (United States)
Craig L. Driver is an author at National Cancer Institute specializing in medicine, pharmacology, and carcinogenesis.
Publications per year
1992–2011
Chemoprevention of Mammary Carcinogenesis in the Rat: Combined Use of Raloxifene and 9-cis-Retinoic Acid
Mario A. Anzano, Christopher W. Peer, Joseph M. Smith et al. · JNCI Journal of the National Cancer Institute · 1996 · 171 citations
Medicine, Oncology, Pharmacology +16
1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
Mario A. Anzano, Joseph M. Smith, Milan R. Uskoković et al. · PubMed · 1994 · 138 citations
Medicine, Oncology, Pharmacology +17
Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.
M. Scott Lucia, Mario A. Anzano, M. V. Slayter et al. · PubMed · 1995 · 96 citations
Medicine, Endocrinology, Pharmacology +16
Enhancement of tumorigenesis by N-nitrosodiethylamine, N-nitrosopyrrolidine and N6(methylnitroso)-adenosine by ethanol
Lucy M. Anderson, John Carter, Craig L. Driver et al. · Cancer Letters · 1993 · 27 citations
Medicine, Cancer Biology, Oncology +6
Characterization of ethanol's enhancement of tumorigenesis by <i>N</i>-nitrosodimethylamine in mice
Lucy M. Anderson, John Carter, Daniel Logsdon et al. · Carcinogenesis · 1992 · 25 citations
Medicine, Pharmacology, Toxicology +8
1–5 of 8